These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25264075)

  • 21. Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38α.
    Getlik M; Grütter C; Simard JR; Nguyen HD; Robubi A; Aust B; van Otterlo WA; Rauh D
    Eur J Med Chem; 2012 Feb; 48():1-15. PubMed ID: 22154891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase.
    Goldstein DM; Alfredson T; Bertrand J; Browner MF; Clifford K; Dalrymple SA; Dunn J; Freire-Moar J; Harris S; Labadie SS; La Fargue J; Lapierre JM; Larrabee S; Li F; Papp E; McWeeney D; Ramesha C; Roberts R; Rotstein D; San Pablo B; Sjogren EB; So OY; Talamas FX; Tao W; Trejo A; Villasenor A; Welch M; Welch T; Weller P; Whiteley PE; Young K; Zipfel S
    J Med Chem; 2006 Mar; 49(5):1562-75. PubMed ID: 16509574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
    Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.
    Quan ML; Lam PY; Han Q; Pinto DJ; He MY; Li R; Ellis CD; Clark CG; Teleha CA; Sun JH; Alexander RS; Bai S; Luettgen JM; Knabb RM; Wong PC; Wexler RR
    J Med Chem; 2005 Mar; 48(6):1729-44. PubMed ID: 15771420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors.
    Filippov AK; Fernández-Fernández JM; Marsh SJ; Simon J; Barnard EA; Brown DA
    Mol Pharmacol; 2004 Sep; 66(3):468-77. PubMed ID: 15322238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil.
    Kobayashi T; Washiyama K; Ikeda K
    Neuropsychopharmacology; 2006 Mar; 31(3):516-24. PubMed ID: 16123769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Yoshida T; Akahoshi F; Sakashita H; Kitajima H; Nakamura M; Sonda S; Takeuchi M; Tanaka Y; Ueda N; Sekiguchi S; Ishige T; Shima K; Nabeno M; Abe Y; Anabuki J; Soejima A; Yoshida K; Takashina Y; Ishii S; Kiuchi S; Fukuda S; Tsutsumiuchi R; Kosaka K; Murozono T; Nakamaru Y; Utsumi H; Masutomi N; Kishida H; Miyaguchi I; Hayashi Y
    Bioorg Med Chem; 2012 Oct; 20(19):5705-19. PubMed ID: 22959556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GIRK channel activation via adenosine or muscarinic receptors has similar effects on rat atrial electrophysiology.
    Wang X; Liang B; Skibsbye L; Olesen SP; Grunnet M; Jespersen T
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):192-8. PubMed ID: 23609329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
    Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
    Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists.
    Atobe M; Naganuma K; Kawanishi M; Morimoto A; Kasahara K; Ohashi S; Suzuki H; Hayashi T; Miyoshi S
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6569-76. PubMed ID: 24252546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel competitive class of α-glucosidase inhibitors: (E)-1-phenyl-3-(4-styrylphenyl)urea derivatives.
    Kim JY; Lee JW; Kim YS; Lee Y; Ryu YB; Kim S; Ryu HW; Curtis-Long MJ; Lee KW; Lee WS; Park KH
    Chembiochem; 2010 Oct; 11(15):2125-31. PubMed ID: 20827790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
    Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
    Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of new N-phenylpyrazole derivatives with potent antimicrobial activity.
    Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
    Bioorg Med Chem; 2008 Apr; 16(8):4569-78. PubMed ID: 18313934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model.
    Kanbara T; Nakamura A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kanemasa T
    Neurosci Lett; 2014 Sep; 580():119-24. PubMed ID: 25128218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunits.
    Ciruela F; Fernández-Dueñas V; Sahlholm K; Fernández-Alacid L; Nicolau JC; Watanabe M; Luján R
    Eur J Neurosci; 2010 Oct; 32(8):1265-77. PubMed ID: 20846323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).
    Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3421-6. PubMed ID: 23591112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 1998 Feb; 123(3):421-6. PubMed ID: 9504382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous multimeric assembly is essential for K+ channel activity of neuronal and cardiac G-protein-activated inward rectifiers.
    Duprat F; Lesage F; Guillemare E; Fink M; Hugnot JP; Bigay J; Lazdunski M; Romey G; Barhanin J
    Biochem Biophys Res Commun; 1995 Jul; 212(2):657-63. PubMed ID: 7626080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
    Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3416-20. PubMed ID: 23591110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels.
    Zhou W; Arrabit C; Choe S; Slesinger PA
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6482-7. PubMed ID: 11353868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.